Basic Information
Glaucus Proteomics BV Develops Next-Generation Antibody and Protein Array Technologies to Accelerate and Optimize Drug Development and Disease Management. The company was founded in 2000 and is headquartered in Utrecht, Netherlands.
Glaucus Proteomics BV
Utrecht,Utrecht,Netherlands
15~50 people
January 01, 2000
--
--
Enterprise Profile
Technology